Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.
Also called NCT05419115
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 172 participants
- Registry
-
NCT05419115
-
- Other papers using this trial's data
- Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failure
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT05419115. Randomized; no masking; primary purpose treatment. Start 2022-11-17 (actual); primary completion 2026-03-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
- Acronym
- SUBCUT-HF II
- Condition
- Heart Failure
- Intervention (Drug)
- SQIN-Furosemide
- Intervention (Device)
- SQIN-Infusor
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
Record details
- Record id
cardio:ct-nct05419115- Content hash
9f350a834fdd5aff405d164070cd7740b3d3759149a006e310235b033781e3d6